Matches in Wikidata for { <http://www.wikidata.org/entity/Q92072051> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92072051 description "article scientifique publié en 2019" @default.
- Q92072051 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92072051 description "bài báo khoa học" @default.
- Q92072051 description "scientific article published on 22 July 2019" @default.
- Q92072051 description "wetenschappelijk artikel" @default.
- Q92072051 description "наукова стаття, опублікована 22 липня 2019" @default.
- Q92072051 name "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 name "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 type Item @default.
- Q92072051 label "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 label "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 prefLabel "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 prefLabel "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 P1433 Q92072051-ABA0E3CB-9C02-42F1-8C98-947FC5D58A79 @default.
- Q92072051 P1476 Q92072051-B2955BC3-7BF0-4396-A4D8-AABFCDE82004 @default.
- Q92072051 P2093 Q92072051-5B7EAECD-31D5-4C20-A20C-CFCA74917FBE @default.
- Q92072051 P2093 Q92072051-679802E9-5614-42AC-937B-18830A723C55 @default.
- Q92072051 P2093 Q92072051-806F258F-626D-41F4-9A44-97395644FA81 @default.
- Q92072051 P2093 Q92072051-C7635DB0-5477-4B06-879C-311F7C720392 @default.
- Q92072051 P2093 Q92072051-E6CD7C95-48C9-49DA-B3CD-F693B566B528 @default.
- Q92072051 P2093 Q92072051-F52E194D-5B76-483C-9C99-51A54295A866 @default.
- Q92072051 P304 Q92072051-2E232444-6947-4DE7-866B-2DDD459D4C54 @default.
- Q92072051 P31 Q92072051-430115AB-F305-41CC-86B1-B51C4BF875C6 @default.
- Q92072051 P356 Q92072051-1B400F18-37C9-47C5-94F0-2613EB89390D @default.
- Q92072051 P433 Q92072051-B7D6F6CC-0751-4657-9A25-506745A8A1B2 @default.
- Q92072051 P478 Q92072051-E2E06B15-050A-4494-B7EE-EFDDE5990672 @default.
- Q92072051 P577 Q92072051-C8606D30-EE2E-4D35-AC39-767755CCDA53 @default.
- Q92072051 P698 Q92072051-4AFC57B7-BD19-4C48-82F8-E938AE68CC01 @default.
- Q92072051 P921 Q92072051-738C1E1D-96F6-45D4-8C4F-6EBCE5717515 @default.
- Q92072051 P921 Q92072051-7EF2DBAC-542E-40BA-8B53-E08B4CBF8850 @default.
- Q92072051 P356 JCO.19.00891 @default.
- Q92072051 P698 31329518 @default.
- Q92072051 P1433 Q400292 @default.
- Q92072051 P1476 "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma" @default.
- Q92072051 P2093 "Daisuke Kiuchi" @default.
- Q92072051 P2093 "Eriko Satomi" @default.
- Q92072051 P2093 "Hiroto Ishiki" @default.
- Q92072051 P2093 "Ken Masuda" @default.
- Q92072051 P2093 "Masaki Shimizu" @default.
- Q92072051 P2093 "Shunsuke Oyamada" @default.
- Q92072051 P304 "2293-2294" @default.
- Q92072051 P31 Q13442814 @default.
- Q92072051 P356 "10.1200/JCO.19.00891" @default.
- Q92072051 P433 "25" @default.
- Q92072051 P478 "37" @default.
- Q92072051 P577 "2019-07-22T00:00:00Z" @default.
- Q92072051 P698 "31329518" @default.
- Q92072051 P921 Q18557602 @default.
- Q92072051 P921 Q42824440 @default.